Literature DB >> 23662960

A randomised clinical trial to assess the effect of a dual treatment on myopia progression: the Cambridge Anti-Myopia Study.

Peter M Allen1, Hema Radhakrishnan, Holly Price, Sheila Rae, Baskar Theagarayan, Richard I Calver, Ananth Sailoganathan, Keziah Latham, Daniel J O'Leary.   

Abstract

PURPOSE: To evaluate the effect of a dual treatment modality for myopia, by improving accommodative functions, on myopia progression.
METHODS: A double blind randomised control trial was conducted on 96 subjects. The treatment modality for the trial employed custom designed contact lenses which control spherical aberration in an attempt to optimise static accommodation responses during near-work, and a vision-training programme to improve accommodation dynamics. Myopia progression was assessed over a 2 year period using cycloplegic autorefraction and biometry.
RESULTS: The mean progression was found to be -0.33 Dioptres (D) over the 2 years of the study. There was no interaction between contact lens treatment and vision training treatment at 24 months (p = 0.72). There was no significant treatment effect of either Vision Training or Contact Lens Spherical Aberration control on myopia progression.
CONCLUSIONS: This study is unable to demonstrate that the progression of myopia can be reduced over a 2 year period by either of the two treatments aimed at improving accommodative function. Neither treatment group (contact lens or vision training) progressed at a slower rate over the 2 years of the study than did the appropriate control group. Ophthalmic & Physiological Optics
© 2013 The College of Optometrists.

Entities:  

Mesh:

Year:  2013        PMID: 23662960     DOI: 10.1111/opo.12035

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  6 in total

1.  Myopia--yesterday, today, and tomorrow.

Authors:  Donald O Mutti; Jane Gwiazda; Thomas T Norton; Earl L Smith; Frank Schaeffel; Chi-ho To
Journal:  Optom Vis Sci       Date:  2013-11       Impact factor: 1.973

2.  Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial.

Authors:  Jeffrey J Walline; Maria K Walker; Donald O Mutti; Lisa A Jones-Jordan; Loraine T Sinnott; Amber Gaume Giannoni; Katherine M Bickle; Krystal L Schulle; Alex Nixon; Gilbert E Pierce; David A Berntsen
Journal:  JAMA       Date:  2020-08-11       Impact factor: 56.272

3.  Interventions to slow progression of myopia in children.

Authors:  Jeffrey J Walline; Kristina B Lindsley; S Swaroop Vedula; Susan A Cotter; Donald O Mutti; Sueko M Ng; J Daniel Twelker
Journal:  Cochrane Database Syst Rev       Date:  2020-01-13

4.  Effect of Vision Therapy on Accommodation in Myopic Chinese Children.

Authors:  Martin Ming-Leung Ma; Mitchell Scheiman; Cuiyun Su; Xiang Chen
Journal:  J Ophthalmol       Date:  2016-12-21       Impact factor: 1.909

Review 5.  Bifocal and Multifocal Contact Lenses for Presbyopia and Myopia Control.

Authors:  Laura Remón; Pablo Pérez-Merino; Rute J Macedo-de-Araújo; Ana I Amorim-de-Sousa; José M González-Méijome
Journal:  J Ophthalmol       Date:  2020-03-27       Impact factor: 1.909

6.  Higher-Order Aberrations and Axial Elongation in Myopic Children Treated With Orthokeratology.

Authors:  Jason K Lau; Stephen J Vincent; Sin-Wan Cheung; Pauline Cho
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.